Sign in

CIK 0001427570

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Vyome Holdings, Inc

Sign in to watch
Ticker
HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-429-6680
Business address
1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
Former names
ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-16 Stevenson Sharon Director Grant or award · Stock Option +27,250 27,250
2020-09-16 Stevenson Sharon Director Grant or award · Stock Option (Right to Buy) +27,250 27,250
2019-08-06 Stevenson Sharon Director Purchase +7,500 $4.00 $30K 18,061
2019-08-06 Stevenson Sharon Director Purchase · Warrants (Right to Buy) +5,625 5,625
2019-07-23 Stevenson Sharon Director Grant or award +78,125 105,597
2018-08-23 Stevenson Sharon Director Grant or award +27,472 $1.82 $50K 27,472
2018-06-13 Stevenson Sharon Director Grant or award · Stock Option (Right to Buy) +81,774 81,774
2017-06-06 Stevenson Sharon Director Grant or award · Stock Option (Right to Buy) +36,554 36,554
2017-05-09 Stevenson Sharon Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2016-11-09 Stevenson Sharon Director Grant or award · Stock Option (right to buy) +46,500 46,500
2016-10-12 Stevenson Sharon Director Conversion +190,780 190,780
2016-10-12 Stevenson Sharon Director Conversion +266,829 457,609
2016-10-12 Stevenson Sharon Director Conversion +40,995 498,604
2016-10-12 Stevenson Sharon Director Conversion +161,504 161,504
2016-10-12 Stevenson Sharon Director Conversion +119,441 280,945
2016-10-12 Stevenson Sharon Director Conversion +47,629 546,233
2016-10-12 Stevenson Sharon Director Conversion +60,290 341,235
2016-10-12 Stevenson Sharon Director Conversion · Series A Preferred Stock −143,677 0
2016-10-12 Stevenson Sharon Director Conversion · Series B Preferred Stock −266,829 0
2016-10-12 Stevenson Sharon Director Conversion · Series C Preferred Stock −40,995 0

Page 1 of 2 · 26 trades